Imexpharm Corp 2024 AR2
The report highlights Imexpharm's performance in 2024, during which the company achieved a gross revenue of VND 2,513 billion, representing an 18.9% year-over-year growth, and a pre-tax profit of VND 404 billion. Imexpharm expanded its production capacity to 12 EU-GMP certified lines and successfully completed a 1:1 bonus share issuance, raising its charter capital to VND 1,540 billion to become the largest listed pharmaceutical company by charter capital in Vietnam. On the sustainability front, the company reduced its electricity consumption intensity by 10% and water consumption intensity by 13%, while achieving a 15% material recycling rate. Additionally, Imexpharm was recognized as the top place to work in Vietnam's healthcare sector.
Company: Imexpharm Corp
Sector: Manufacturing
Country: Vietnam
Year: 2024
Type: AR2
Pages: 111
Back to company
Imexpharm Corp
Annual Report
The report highlights Imexpharm's performance in 2024, during which the company achieved a gross revenue of VND 2,513 billion, representing an 18.9% year-over-year growth, and a pre-tax profit of VND 404 billion. Imexpharm expanded its production capacity to 12 EU-GMP certified lines and successfully completed a 1:1 bonus share issuance, raising its charter capital to VND 1,540 billion to become the largest listed pharmaceutical company by charter capital in Vietnam. On the sustainability front, the company reduced its electricity consumption intensity by 10% and water consumption intensity by 13%, while achieving a 15% material recycling rate. Additionally, Imexpharm was recognized as the top place to work in Vietnam's healthcare sector.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Women on Board
Employees